Reinventing Biologic Drug Development
with AI Guided Design

Final Agenda Just Announced

The third annual PEGS AI Summit, launched as the BioLogic Summit in 2025, will train and guide our growing community to empower the new research paradigm of integrating AI/ML and computational tools into the complex world of biologic drug discovery and protein engineering. This field is growing exponentially and PEGS AI will allow participants to take an active role in planning the industry's future direction. More than 2,200 delegates have attended an AI/ML  program at PEGS Boston or PEGS Europe since 2021! Hear from a few past attendees in this testimonial video.

AI/ML has transformative potential and is being used in all stages of the biologic pipeline, from discovering new biology and generating hypotheses, identifying new targets, addressing challenging targets, pioneering new approaches in de novo design, optimizing drug candidates, defining properties to determine developability early on, maximizing safety profiles, and advancing complex biologics to the clinic.

The event features four conference tracks, luminary plenary keynotes, moderated small-group discussions, and two one-day training seminars to meet the needs of participants at every level. We welcome you to join this important nexus to learn from conversations with leaders in the community about the near-term implementation and implications of machine learning tools and AI technologies in pharma and biotech.

For maximum savings, reserve your spot by September 18. Bring your whole team to the PEGS AI Summit and save up to 30% with a group registration.